Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Roy First

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
Transplantation|March 9, 2005
United network for organ sharing publication on scientific registry of transplant recipients central nervous system donor cancer transmission dataJoseph F Buell, Thomas M Beebe, Thomas G Gross, et al.
Transplantation|July 29, 2003
Donors with central nervous system malignancies: are they truly safe?Joseph F Buell, Jennifer Trofe, Gopalan Sethuraman, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 11, 2005
Multivariate analysis of risk factors for acute rejection in early corticosteroid cessation regimens under modern immunosuppressionE Steve Woodle, Rita R Alloway, Joseph F Buell, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 16, 2007
One-year results with extended-release tacrolimus/MMF, tacrolimus/MMF and cyclosporine/MMF in de novo kidney transplant recipientsH T Silva, H C Yang, M Abouljoud, et al.
Transplantation|May 14, 2008
Conversion from cyclosporine to tacrolimus in patients at risk for chronic renal allograft failure: 60-month results of the CRAF StudyFuad S Shihab, Thomas H Waid, David J Conti, et al.
Surgery|October 31, 2002
Incidental diagnosis of gastric cancer in transplant recipients improves patient survivalJoseph F Buell, Thomas Husted, Michael J Hanaway, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 12, 2005
Analysis of factors that influence survival with post-transplant lymphoproliferative disorder in renal transplant recipients: the Israel Penn International Transplant Tumor Registry experienceJennifer Trofe, Joseph F Buell, Thomas M Beebe, et al.
Transplantation|February 10, 2009
A prospective trial of a steroid-free/calcineurin inhibitor minimization regimen in human leukocyte antigen (HLA)-identical live donor renal transplantationJennifer K Walker, Rita R Alloway, Prabir Roy-Chaudhury, et al.
Transplantation|December 14, 2004
Experience with 274 cardiac transplant recipients with posttransplant lymphoproliferative disorder: a report from the Israel Penn International Transplant Tumor RegistryMeredith J Aull, Joseph F Buell, Jennifer Trofe, et al.
Transplantation|February 21, 2013
Acute rejection characteristics from a prospective, randomized, double-blind, placebo-controlled multicenter trial of early corticosteroid withdrawalA Osama Gaber, Linda W Moore, Rita R Alloway, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Transplantation|March 9, 2005
United network for organ sharing publication on scientific registry of transplant recipients central nervous system donor cancer transmission dataJoseph F Buell, Thomas M Beebe, Thomas G Gross, et al.
Transplantation|July 29, 2003
Donors with central nervous system malignancies: are they truly safe?Joseph F Buell, Jennifer Trofe, Gopalan Sethuraman, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 11, 2005
Multivariate analysis of risk factors for acute rejection in early corticosteroid cessation regimens under modern immunosuppressionE Steve Woodle, Rita R Alloway, Joseph F Buell, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 16, 2007
One-year results with extended-release tacrolimus/MMF, tacrolimus/MMF and cyclosporine/MMF in de novo kidney transplant recipientsH T Silva, H C Yang, M Abouljoud, et al.
Transplantation|May 14, 2008
Conversion from cyclosporine to tacrolimus in patients at risk for chronic renal allograft failure: 60-month results of the CRAF StudyFuad S Shihab, Thomas H Waid, David J Conti, et al.
Surgery|October 31, 2002
Incidental diagnosis of gastric cancer in transplant recipients improves patient survivalJoseph F Buell, Thomas Husted, Michael J Hanaway, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 12, 2005
Analysis of factors that influence survival with post-transplant lymphoproliferative disorder in renal transplant recipients: the Israel Penn International Transplant Tumor Registry experienceJennifer Trofe, Joseph F Buell, Thomas M Beebe, et al.
Transplantation|February 10, 2009
A prospective trial of a steroid-free/calcineurin inhibitor minimization regimen in human leukocyte antigen (HLA)-identical live donor renal transplantationJennifer K Walker, Rita R Alloway, Prabir Roy-Chaudhury, et al.
Transplantation|December 14, 2004
Experience with 274 cardiac transplant recipients with posttransplant lymphoproliferative disorder: a report from the Israel Penn International Transplant Tumor RegistryMeredith J Aull, Joseph F Buell, Jennifer Trofe, et al.
Transplantation|February 21, 2013
Acute rejection characteristics from a prospective, randomized, double-blind, placebo-controlled multicenter trial of early corticosteroid withdrawalA Osama Gaber, Linda W Moore, Rita R Alloway, et al.
Pageof 6